Incidence of antibiotic prescribing in dental practice in Norway and its contribution to national consumption

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 6, 2007, Pages 1161-1166

  Al Haroni, Mohammed ^a,b,c   Skaug, Nils ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Laboratory of Oral Microbiology   (Norway)

Author keywords

Antibiotics; Dentists; Prescriptions; Utilization

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; METRONIDAZOLE; OXYTETRACYCLINE; PENICILLIN DERIVATIVE; PENICILLIN V; SPIRAMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENTAL PRACTICE; DENTIST; DRUG USE; HEALTH CARE UTILIZATION; HUMAN; INCIDENCE; MOUTH FLORA; NORWAY; OUTPATIENT; PHYSICIAN; PRESCRIPTION; PREVALENCE; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; DATABASES, FACTUAL; DENTISTRY; DRUG UTILIZATION; HUMANS; NORWAY; PRESCRIPTIONS, DRUG;

EID: 34447500576     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm090     Document Type: Article

References (31)

1. Weber JT, Courvalin P. An emptying quiver: Antimicrobial drugs and resistance. Emerg Infect Dis 2005; 11: 791-3.
2. Bonten MJ, Slaughter S, Ambergen AW et al., The role of 'colonization pressure' in the spread of vancomycin-resistant enterococci: An important infection control variable. Arch Intern Med 1998; 158: 1127-32.
3. Nourse C, Byme C, Murphy H et al., Eradication of vancomycin-resistant Enterococcus faecium from a paediatric oncology unit and prevalence of colonization in hospitalized and community-based children. Epidemiol Infect 2000; 124: 53-9.
4. Montecalvo MA, Jarvis WR, Uman J et al., Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern, Med 1999; 131: 269-72.
5. Norwegian Institute of Public Health. Department of Pharmacoepidemiology, Division of Epidemiology. http://www.fhi.no/ eway/default0.asp?pid&225&oid=0&e&0&trg= MainArea_4807&MainArea_4807=4953:0:1,1163:1:0:0:4807;4946;::0:0:0: (6 January 2007, date last accessed).
6. WHO Collaborating Centre to Drug Statistics Methodology. The ATC/DDD System. http://www.whocc.no/atcddd/ (6 January 2007, date last accessed).
7. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-3.
8. Slots J, Pallasch TJ. Dentists' role in halting antimicrobial resistance. J Dent Res 1996; 75: 1338-41.
9. Sweeney LC, Dave J, Chambers PA et al., Antibiotic resistance in general dental practice - a cause for concern? J Antimicrob Chemother 2004; 53: 567-76.
10. LeBlanc DJ, Flynn TR, Simos C et al., Antibiotics and the treatment of infectious diseases. In: Lamont R, Bume R, Lantz M et al., ed. Oral Microbiology and Immunology. Washington, DC: ASM Press, 2006; 393-422.
11. American Dental Association Council on Scientific Affairs. Combating antibiotic resistance. J Am Dent Assoc 2004; 135: 484-7.
12. Tong DC, Rothwell BR. Antibiotic prophylaxis in dentistry: A review and practice recommendations. J Am Dent Assoc 2000; 131: 366-74.
13. Palmer NA. Revisiting the role of dentists in prescribing antibiotics. Dent Update 2003; 30: 570-4.
14. Haas DA, Epstein JB, Eggert FM. Antimicrobial resistance: Dentistry's role. J. Can Dent Assoc 1998; 64: 496-502.
15. The Norwegian Registration Authority for Health Personnel. http://www.safh.no/ (6 January 2007, date last accessed).
16. Monnet DL, Molstad S, Cars O. Defined daily doses of antimicrobials reflect antimicrobial prescriptions in ambulatory care. J Antimicrob Chemother 2004; 53: 1109-11.
17. Al-Haroni MH, Skaug N, Al-Hebshi NN. Prevalence of subgingival bacteria resistant to aminopenicillins and metronidazole in dental patients from Yemen and Norway. Int J Antimicrob Agents 2006; 27: 217-23.
18. Palmer NO, Martin MV, Pealing R et al., An analysis of antibiotic prescriptions from general dental practitioners in England. J Antimicrob Chemother 2000; 46: 1033-5.
19. Roy KM, Bagg J. Antibiotic prescribing by general dental practitioners in the Greater Glasgow Health Board, Scotland. Br Dent J 2000; 188: 674-6.
20. Salako NO, Rotimi VO, Adib SM et al., Pattern of antibiotic prescription in the management of oral diseases among dentists in Kuwait. J Dent 2004; 32: 503-9.
21. Jaunay T, Sambrook P, Goss A. Antibiotic prescribing practices by South Australian general dental practitioners. Aust Dent J 2000; 45 179-86 (quiz 214).
22. Goossens H, Ferech M, Vander Stichele R et al., Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005; 365: 579-87.
23. Standing Medical Advisory Committee. The Path of Least Resistance. London: Department of Health, 1998.
24. Rotzetter PA, Le Liboux A, Pichard E et al., Kinetics of spiramycin/metronidazole (Rodogyl) in human gingival crevicular fluid, saliva and blood. J Clin Periodontol 1994; 21: 595-600.
25. Roche Y, Yoshimori RN. In vitro activity of spiramycin metronidazole alone or in combination against clinical isolates from odontogenic abscesses. J Antimicrob Chemother 1997; 40: 353-7.
26. Pallasch TJ. Antibiotic resistance. Dent Clin North Am 2003; 47 623-39.
27. Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000 2002; 28: 106-76.
28. Carrotte P. Endodontics: Part 3. Treatment of endodontic emergencies. Br Dent J 2004; 197: 299-305.
29. Samaranayake LP. Antimicrobial chemotherapy. In: Essential Microbiology for Dentisity. Philadelphia, PA: Churchill Livingstone Elsevier, 2006; 67-76.
30. Al-Haroni M, Skaug N. Knowledge of prescribing antimicrobials among Yemeni general dentists. Acta Odontol Scand 2006; 64: 274-80.
31. Palmer NO, Martin MV, Pealing R et al., Antibiotic prescribing knowledge of National Health Service general dental practitioners in England and Scotland. J Antimicrob Chemother 2001; 47: 233-7.